Avidity Partners Management LP
Position in DNTH — Dianthus Therapeutics, Inc. /DE/
CIK 1791827
DALLAS, TX
Position in DNTH
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$205,115,856
+$28,532,735 QoQ
Shares Held
2,104,184
0.0% QoQ
Ownership
3.76%
of shares outstanding
% of Portfolio
32.85%
of 13F equity value
Holder Rank
#9
of 269 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DNTH Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Avidity Partners Management LP holds $524,784,316 across 27 Biotechnology names. DNTH ranks #1 (39.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DNTH |
Dianthus Therapeutics, Inc. /DE/
This page
|
2,104,184 | $205,115,856 | |
| 2 | CGON |
CG Oncology, Inc.
|
1,398,948 | $99,395,255 | |
| 3 | ORKA |
Oruka Therapeutics, Inc.
|
760,424 | $72,369,552 | |
| 4 | JBIO |
Jade Biosciences, Inc.
|
1,700,708 | $37,789,731 | |
| 5 | ELVN |
Enliven Therapeutics, Inc.
|
550,000 | $27,912,500 | |
| 6 | AKTS |
Aktis Oncology, Inc.
|
484,200 | $15,605,766 | |
| 7 | PVLA |
Palvella Therapeutics, Inc.
|
70,000 | $10,697,400 | |
| 8 | IMUX |
Immunic, Inc.
|
669,941 | $10,296,993 |
All Filings in DNTH
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $205,115,856 | 2,104,184 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $176,583,121 | 2,104,184 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $86,713,422 | 2,104,184 | Shares | Sole | 2026-02-13 | |
| 2025-11-17 | $87,008,008 | 2,104,184 | Shares | Sole | 2025-11-19 | |
| 2025-09-30 | $126,084,640 | 3,204,184 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $32,470,264 | 1,742,902 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $31,217,162 | 1,720,902 | Shares | Sole | 2025-05-15 | |
| 2025-03-17 | $74,235,289 | 3,378,939 | Shares | Sole | 2025-03-19 | |
| 2024-12-31 | $62,631,400 | 2,873,000 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $79,873,784 | 2,917,231 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $75,497,938 | 2,917,231 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $81,526,620 | 2,717,554 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $12,662,561 | 1,217,554 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $16,643,963 | 1,217,554 | Shares | Sole | 2023-11-14 | |
| No filing history on record for this holder in this stock. | ||||||